Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands

Hormone and Metabolic Research

Volumn 39, Issue 2, 2007, Pages 166-170

  Krause, K ^a   Schnitger, A ^a   Fimmel, S ^a   Glass, E ^a   Zouboulis, C C ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DESSAU MEDICAL CENTER   (Germany)

Author keywords

CRH; Interleukins; Lipogenesis; Proliferation; Skin; SZ95 sebocytes

Indexed keywords

ANTALARMIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NEUROPEPTIDE;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEBACEOUS GLAND;

CARRIER PROTEINS; CELL PROLIFERATION; CELL SURVIVAL; CORTICOTROPIN-RELEASING HORMONE; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; PEPTIDES; PYRIMIDINES; PYRROLES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEBACEOUS GLANDS; SIGNAL TRANSDUCTION; SKIN; SKIN PHYSIOLOGY; UROTENSINS;

EID: 34047235651     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-961811     Document Type: Article

References (34)

1. Aguilera G: Corticotropin releasing hormone, receptor regulation and the stress response. Trends Endocrinol Metab 1998; 9: 329-336
2. Chrousos GP, Gold PW: The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992; 267: 1244-1252
3. Dautzenberg FM, Hauger RL: The CRH peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 2002; 23: 71-77
4. Grammatopoulos DK, Chrousos GP: Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab 2002; 13: 436-444
5. Perrin MH, Vale WW: Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci 1999; 885: 312-328
6. Linton EA, Woodman JR, Asboth G, Glynn BP, Plested CP, Bernal AL: Corticotrophin releasing hormone: its potential for a role in human myometrium. Exp Physiol 2001; 86: 273-281
7. Slominski A, Wortsman J, Luger T, Paus R, Salomon S: Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000; 80: 979-1020
8. Slominski A, Wortsman J, Pisarchik A, Zbytek B, Linton EA, Mazurkiewicz JE, Wei ET: Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 2001; 15: 1678-1693
9. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, De Souza EB: Corticotropin- releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci 1996; 17: 166-172
10. Slominski A, Pisarchik A, Tobin DJ, Mazurkiewicz JE, Wortsman J: Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology 2004; 145: 941-950
11. Zouboulis CC, Seltmann H, Hiroi N, Chen WC, Young M, Oeff M, Scherbaum WA, Orfanos CE, McCann SM, Bornstein SR: Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA 2002; 99: 7148-7153
12. Kono M, Nagata H, Umemura S, Kawana S, Osamura RY: In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. FASEB J 2001; 15: 2297-2299
13. Park HJ, Kim HJ, Lee JH, Lee JY, Cho BK, Kang JS, Kang H, Yang Y, Cho DH: Corticotropin-releasing hormone (CRH) downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase (MAPK) pathway. J Invest Dermatol 2005; 124: 751-755
14. Zbytek B, Pfeffer LM, Slominski AT: Corticotropin-releasing hormone stimulates NF-kappa B in human epidermal keratinocytes. J Endocrinol 2004; 181: 1-7
15. Zouboulis CC, Seltmann H, Neitzel H, Orfanos CE: Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol 1999; 113: 1011-1020
16. Slominski AT, Botchkarev V, Choudhry M, Fazal N, Fechner K, Furkert J, Krause E, Roloff B, Sayeed M, Wei E, Zbytek B, Zipper J, Wortsman J, Paus R: Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci 1999; 885: 287-311
17. Pisarchik A, Slominski AT: Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. Faseb J 2001; 15: 2754-2756
18. Slominski A, Zbytek B, Pisarchik A, Slominski RM, Zmijewski MA, Wortsman J: CRH functions as a growth factor/cytokine in the skin. J Cell Physiol 2006; 206: 780-791
19. Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, Kees F, Straub RH, Paus R: Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J 2005; 19: 1332-1334
20. Ganceviciene R, Marciukaitiene I, Graziene V, Rimkevicius A, Zouboulis CC: New accents in the pathogenesis of acne vulgaris. Acta Medica, in press
21. Kempuraj D, Papadopoulou NG, Lytinas M, Huang M, Kandere-Grzybowska K, Madhappan B, Boucher W, Christodoulou S, Athanassiou A, Theoharides TC: Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology 2004; 145: 43-48
22. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE: Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 2001; 98: 2843-2848
23. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW: Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 2001; 98: 7570-7575
24. Lawrence AJ, Krstew EV, Dautzenberg FM, Ruhmann A: The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain. Br J Pharmacol 2002; 136: 896-904
25. Zbytek B, Mysliwski A, Slominski A, Wortsman J, Wei ET, Mysliwska J: Corticotropin-releasing hormone affects cytokine production in human HaCaT keratinocytes. Life Sci 2002; 70: 1013-1021
26. Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Kempuraj D, Conti P: Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci 2004; 25: 563-568
27. Zbytek B, Pfeffer LM, Slominski AT: Corticotropin-releasing hormone stimulates NF-kappaB in human epidermal keratinocytes. J Endocrinol 2004; 181: R1-R7
28. Fazal N, Slominski A, Choudhry MA, Wei ET, Sayeed MM: Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Lett 1998; 435: 187-190
29. Wiesner B, Roloff B, Fechner K, Slominski A: Intracellular calcium measurements of single human skin cells after stimulation with corticotropin-releasing factor and urocortin using confocal laser scanning microscopy. J Cell Sci 2003; 116: 1261-1268
30. Bohm M, Schiller M, Stander S, Seltmann H, Li Z, Brzoska T, Metze D, Schioth HB, Skottner A, Seiffert K, Zouboulis CC, Luger TA: Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 2002; 118: 533-539
31. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-1652
32. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, Rosenfield R: What is the pathogenesis of acne? Exp Dermatol 2005; 14: 143-152
33. Zouboulis CC, Xia L, Akamatsu H, Seltmann H, Fritsch M, Hornemann S, Ruhl R, Chen W, Nau H, Orfanos CE: The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology 1998; 196: 21-31
34. Quevedo ME, Slominski A, Pinto W, Wei E, Wortsman J: Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In Vitro Cell Dev Biol Anim 2001; 37: 50-54